No Data
Hong Kong stock concept tracking | The end of medical insurance negotiations is very encouraging for innovative drugs to be included in medical insurance at reasonable prices (with concept stocks)
The on-site negotiation and bidding stages for the adjustment of the national medical insurance pharmaceutical catalog in 2024 officially ended recently.
Historically the most 'competitive'? The Tenth Batch of National Procurement Pharmaceutical Catalog Is Officially Announced with one type having up to 31 companies competing.
①This afternoon, the National Pharmaceutical Joint Procurement Office officially announced the tenth batch of nationally purchased pharmaceutical catalog, with a total of 263 specifications and 62 varieties; ②Several industry insiders have stated that the tenth batch of national procurement will be the largest and most competitive national procurement in history.
Analyst Estimates: Here's What Brokers Think Of Sinopharm Group Co. Ltd. (HKG:1099) After Its Third-Quarter Report
HK stocks anomaly | Sinopharm (01099) fell by nearly 4% during the day, performance in the first three quarters fell short of expectations, institutions lowered the company's target price.
Sinopharm (01099) fell nearly 4% intraday. As of the time of writing, it dropped 3.44% to HKD 19.36, with a turnover of 69.3653 million Hong Kong dollars.
zheshang: Continuous realization of technological innovation upgrade driving the continuous improvement of performance expectations for innovative drugs and industry chain.
The commercialization period of innovative drugs in the industry chain, driven purely by incremental value, is entering the phase of realization. The scarce incremental prosperity of the pharmaceutical sector continues to rise, with increasing international competitiveness, and there is still room for upward valuation.
CICC: Maintains a "outperform" rating on Sinopharm (01099) and a target price of HK$24.7.
CICC lowered sinopharm (01099) 's earnings per share forecasts for 2024/25 by 10.9% and 12.6%.
Earnings Update: Sinopharm Group Co. Ltd. (HKG:1099) Just Reported Its Yearly Results And Analysts Are Updating Their ForecastsNo Data
No Data
